Aaron Pearce
Analyst · Sidoti
Thank you, Michael. Good morning, everyone. I'll start the financial review on Slide number 4. Sales in the second quarter were $265.8 million, which was a decline of 3.9%. And pretax income was $39.4 million, which was a decrease of 7% when compared to the second quarter of last year. Diluted EPS finished at $0.59 this quarter, compared to last year's second quarter EPS of $0.62. We also had solid cash generation again this quarter. Net cash provided by operating activities was a very strong $36.1 million, which is more than 150% higher than the $14.3 million of operating cash flow generated in the second quarter of last year. Moving to Slide number 5, you'll find our quarterly sales trends. Total sales were down 3.9%, which consisted of an organic sales decline of 6.3% and an increase from foreign currency translation of 2.4%. Organic sales continued to improve sequentially in our ID Solutions business as organic sales finished down 6.9%, which was an improvement over the previous two quarters. In Workplace Safety, after two consecutive quarters of solid organic sales growth, we saw a decline of 4.8% this quarter. We experienced weakness in one of our U.S. businesses that primarily sells into very small companies that have been heavily impacted by government mandated shutdowns. We also saw a reduction in the sale of products specifically aimed at fighting the COVID-19 virus, which we were unable to fully offset through increased sales into our core industrial clients. Turning to Slide number 6, you'll see our gross profit margin trending. Our gross profit margin was 48.7% this quarter, compared to 50.3% in the second quarter of last year. This 160 basis point decline was primarily due to reduced sales volumes, combined with product mix challenges in our Workplace Safety business, both of which were partially offset by our continual focus on driving efficiencies in our factories. On Slide number 7, you'll find our SG&A expense trend. SG&A was once again down nicely to $82.2 million this quarter, compared to $87.4 million in the second quarter of last year. And as a percent of sales, SG&A ticked down to 30.9% from 31.6% in the same period of last year. The majority of our SG&A decline was the result of the efficiency actions we've been driving over the last several years, combined with a reduction in discretionary spend. Our SG&A continues to trend downwards, but this does not mean that we are cutting back on investments. Not at all. We are absolutely investing in sales and marketing resources, where it makes sense to drive our top line while at the same time becoming more efficient in our non-customer facing areas. Moving to Slide number 8, you'll find the trending of our investments in research and development. This quarter, we invested $9.9 million in R&D. We continue to have opportunities to invest in new products and we're committed to increasing these investments, while at the same time ensuring that we get the most out of every dollar spent. Our R&D spend was down slightly when compared to the second quarter of last year as a result of reduced headcount and the timing of project spend. But again, we remain committed to R&D, as it is absolutely critical to our long-term success. Slide number 9 illustrates our pretax income trends. Pretax income declined 7% from $42.4 million last year to $39.4 million in the second quarter of this year. This decline was driven by our reduced sales volumes and our lower gross profit margins partially offset by efficiency gains in our SG&A structure. Slide number 10 illustrates our after-tax income and EPS trends. As I mentioned, diluted EPS was $0.59 this quarter, compared to $0.62 in last year's second quarter. On Slide number 11, you'll find a summary of our cash generation which continues to be extremely strong. We generated $36.1 million in cash flow from operating activities and free cash flow was $30.9 million. When compared to last year second quarter, this represents a 153% increase in cash flow from operating activities and a 247% increase in free cash flow. Cash flow from operating activities was equal to 117% of net income this quarter, helping drive our strong cash generation was a sizable reduction in the amount of annual bonuses paid this quarter when compared to the same quarter of last year, and strong working capital management. However, even without the reduction in incentive-based compensation payments, cash generation we've still been up nicely compared to last year, which is a testament to our strong quality of earnings and our disciplined cash-based decision making. Turning to Slide number 12, you'll find the trending of our net cash position. On January 31st, we had $277.6 million of cash and no debt outstanding. This quarter our cash balance increased $21.3 million, even after returning $12.3 million to our shareholders in the form of dividends and buybacks. Our approach to capital allocation is consistent and patient. First, we used our cash to fully fund organic sales and efficiency opportunities throughout the economic cycle. We're funding investments in new product development, sales generating resources, IT improvements, capability, enhancing capital expenditures and CapEx to further automate our facilities. We will absolutely keep funding these investments where it makes sense and where the investments are long-term ROI positive. And second, we focus on returning cash to our shareholders in the form of dividends. Fiscal '21 marks our 35th consecutive year of annual dividend increases. After funding organic investments and dividends, we then deploy our cash in a disciplined manner for either buybacks or acquisitions, where we believe that we have strong synergistic opportunities. Let's move along to our outlook for the rest of fiscal 2021, which is articulated on Slide number 13. Although vaccines are being rolled out around the globe, and governments are certainly taking actions to prop-up the economy, we neither expect an immediate economic recovery, nor a nice steady economic recovery, quite the contrary. We do expect the recovery, but we expect it to be quite choppy as cities and countries around the globe move into and out of various states of lockdown. But again, as we establish our earnings guidance, we do anticipate the economy to continue to improve as we progress through the next six months. As Michael mentioned, we're controlling what we can control. We're staying disciplined on costs, and we're investing to drive sales growth. Given our current view of the macro economy, we expect to finish our fiscal year ending July 31, 2021 with diluted EPS in the range of $2.48 to $2.58 per share, which equates to a range of 1.25 to 1.35 per share in the second half of our fiscal year. This guidance range implies that we expect the EPS to improve somewhere in the range of 58% to 71% in the second half of this fiscal year, when compared to the second half of last year. This guidance is of course contingent upon continued macroeconomic improvements. We're confident that we've taken and will continue to take the right actions today to overcome any economic headwinds and enable us to deliver a strong second half to our fiscal year ending July 31, 2021. Regardless of what the economy throws at us, we'll continue to make the investments necessary to drive organic sales growth, we'll continue to search for acquisitions that advance our strategies, and we'll continue to drive sustainable efficiency gains while being tight on non-revenue generating expenses. Brady's strong balance sheet and strong cash generation combined with our focus on growth positioned us extremely well for the future. I'll now turn the call back over to Michael to cover our divisional results, and provide some closing comments before the Q&A session. Michael?